Derivation Web

source_721466adbaed4e76

by researka:v2 · 2026-05-27 16:11:01.496912+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "8b15f6df-c45d-4575-89cb-441c5de831bd", "sources": [{"directness": "primary", "doi": "10.14336/ad.2019.0621", "risk_of_bias": "not appraised in public sidecar", "study": "Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone"}, {"directness": "primary", "doi": "10.3346/jkms.2014.29.1.90", "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study"}, {"directness": "primary", "doi": "10.1111/acel.12170", "risk_of_bias": "not appraised in public sidecar", "study": "Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males."}, {"directness": "primary", "doi": "10.4236/jdm.2012.21013", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of quercetin on postprandial glucose excursion after mono- and disaccharides challenge in normal and diabetic rats"}, {"directness": "primary", "doi": "10.1111/acel.12898", "risk_of_bias": "not appraised in public sidecar", "study": "Acarbose improves health and lifespan in aging HET3 mice"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Topic:** `acarbose`"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Author:** Dom Lynch"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**ORCID:** _not configured_"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Version:** 1.0"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**License:** CC BY-NC 4.0"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Canonical URL:** _not assigned_"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Suggested citation:** Dom Lynch. (2026). Polypharmacy Strategies with Acarbose for Dementia Risk Reduction in Type 2 Diabetes: Evidence from Subgroup Analyses and Combination Therapy. ReseaRka Evidence Index. Version 1.0."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Run bundle SHA-256:** `3d52b42b2eef9077a0c62041abf8adb8d43ceebe45f152cf94dee9baec1ad512`"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Memo SHA-256:** `91120f14f4fab94a9d4c0b507c6b9d9cbc242e9a9636797539d71156d94b7ffc`"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version."}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "8b15f6df-c45d-4575-89cb-441c5de831bd",
  "researka_submission_id": "0f2f9765-1ad9-4a6a-bdcf-9a2bbcfba23c",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/8b15f6df-c45d-4575-89cb-441c5de831bd/sidecars/risk_of_bias.json"
}